6月9日，赛默飞世尔盘中上涨3.14%，报487.08美元/股，成交额8102.88万美元。生命科学工具和服务板块集体走强，同行业个股中Repligen Corporation涨4.95%、沃特世涨3.26%、丹纳赫涨2.45%、梅特勒-托利多涨2.38%，板块联动效应显著。
消息面上，此前OpenAI推出专注生命科学的新模型GPT-Rosalind并与赛默飞世尔展开合作，AI赋能生命科学主题持续发酵，带动该股自上一交易日469.63美元低位大幅反弹。值得关注的是，汇丰银行此前将赛默飞世尔评级从买入下调至持有、目标价降至540美元，当前股价仍低于分析师平均目标价602.50美元。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.